Caribou Biosciences (CRBU) Property, Plant & Equipment (Net) (QoQ) (2021 - 2026)
Caribou Biosciences (CRBU) Property, Plant & Equipment (Net) (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Caribou Biosciences |
152.90 Mn |
35.27 Mn |
- |
| Date | Value |
| Mar 31, 2026 |
-9.42% |
| Dec 31, 2025 |
-11.03% |
| Sep 30, 2025 |
-7.10% |
| Jun 30, 2025 |
-55.83% |
| Mar 31, 2025 |
-3.95% |
| Dec 31, 2024 |
-1.45% |
| Sep 30, 2024 |
-1.56% |
| Jun 30, 2024 |
3.70% |
| Mar 31, 2024 |
4.91% |
| Dec 31, 2023 |
10.07% |
| Sep 30, 2023 |
7.58% |
| Jun 30, 2023 |
22.01% |
| Mar 31, 2023 |
18.43% |
| Dec 31, 2022 |
19.19% |
| Sep 30, 2022 |
11.90% |
| Jun 30, 2022 |
33.08% |
| Mar 31, 2022 |
23.10% |
| Dec 31, 2021 |
9.16% |
| Sep 30, 2021 |
1.57% |